Mesoblast Ltd. (MESO)
16.84
-0.35
(-2.04%)
USD |
NASDAQ |
Aug 26, 16:00
17.27
+0.43
(+2.55%)
After-Hours: 06:33
Mesoblast Enterprise Value : 2.215B for Aug. 26, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 2.215B |
| August 25, 2026 | 2.260B |
| August 24, 2026 | 2.189B |
| August 21, 2026 | 2.236B |
| August 20, 2026 | 2.291B |
| August 19, 2026 | 2.252B |
| August 18, 2026 | 2.193B |
| August 17, 2026 | 2.238B |
| August 14, 2026 | 2.055B |
| August 13, 2026 | 2.170B |
| August 12, 2026 | 2.207B |
| August 11, 2026 | 2.225B |
| August 10, 2026 | 2.194B |
| August 07, 2026 | 2.099B |
| August 06, 2026 | 2.058B |
| August 05, 2026 | 1.973B |
| August 04, 2026 | 1.952B |
| August 03, 2026 | 1.910B |
| July 31, 2026 | 1.871B |
| July 30, 2026 | 1.920B |
| July 29, 2026 | 1.866B |
| July 28, 2026 | 1.907B |
| July 27, 2026 | 1.921B |
| July 24, 2026 | 2.018B |
| July 23, 2026 | 2.117B |
| Date | Value |
|---|---|
| July 22, 2026 | 2.145B |
| July 21, 2026 | 2.161B |
| July 20, 2026 | 2.188B |
| July 17, 2026 | 2.277B |
| July 16, 2026 | 2.346B |
| July 15, 2026 | 2.395B |
| July 14, 2026 | 2.202B |
| July 13, 2026 | 2.135B |
| July 10, 2026 | 2.035B |
| July 09, 2026 | 1.956B |
| July 08, 2026 | 1.952B |
| July 07, 2026 | 1.886B |
| July 06, 2026 | 1.892B |
| July 02, 2026 | 1.898B |
| July 01, 2026 | 1.861B |
| June 30, 2026 | 1.789B |
| June 29, 2026 | 1.799B |
| June 26, 2026 | 1.745B |
| June 25, 2026 | 1.914B |
| June 24, 2026 | 2.049B |
| June 23, 2026 | 2.027B |
| June 22, 2026 | 2.042B |
| June 18, 2026 | 1.897B |
| June 17, 2026 | 1.845B |
| June 16, 2026 | 1.817B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Immutep Ltd. | -- |
| CSL Ltd. | -- |
| Ceryvyn Therapeutics Ltd. | -- |
| Propanc Biopharma, Inc. | 2.066M |
| Actinogen Medical Ltd. | -- |
Enterprise Value Related Metrics
| Earnings Yield | -4.38% |
| Normalized Earnings Yield | -4.365 |